PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayA large-scale genomic investigation combining genome-wide association data from more than 1.1 million individuals of European ancestry with single-cell transcriptomics has uncovered 125 independent susceptibility loci for psoriasis, including 17 previously unreported genomic regions. Psoriasis is a chronic, heritable autoimmune disorder characterized by recurrent flare-ups and cycles of remission, with twin studies attributing approximately 68 percent of the variation in disease susceptibility to genetic factors. The findings delineate the central roles of myeloid and lymphoid immune cells in driving skin inflammation while uncovering how disease-associated risk genes specifically perturb distinct populations of epidermal keratinocytes and endothelial cells across different structural layers of the skin.
To assemble the genetic discovery cohort, the researchers conducted an inverse-variance weighted meta-analysis across four large-scale genome-wide association studies encompassing 41,983 psoriasis cases and 1,089,702 controls. The integrated datasets comprised the UK Biobank with 408,619 individuals, FinnGen Release 10 with 407,876 individuals, the cohort analyzed by Stuart and colleagues comprising 44,161 individuals, and 23andMe data covering 271,029 participants. To account for self-reported cases in the UK Biobank and 23andMe datasets, the authors applied Duffy's method, with risk allele frequencies yielding estimated true-positive case proportions of 73.85 percent and 37.5 percent, respectively. Across more than 10.3 million common genetic variants with minor allele frequencies above one percent, conditional and joint association analysis resolved 198 independent single-nucleotide polymorphisms across 125 distinct genomic loci exceeding the genome-wide significance threshold of five times ten to the negative eighth power.
Excluding the highly complex major histocompatibility complex locus, 159 independent signals mapped to 122 genomic regions, reflecting a continuous linear increase in discovery power relative to effective sample size. MAGMA gene-set enrichment analyses revealed that genes residing at these susceptibility loci were heavily concentrated in core immunological biological pathways, including immune response mechanisms, mononuclear cell differentiation, and cytokine-mediated signaling pathways. The 17 previously unreported loci harbored genes with established connections to immune regulation such as IRF2BP2, CXCR4, ULBP3, CRTAM, and SOCS3, along with mitochondrial regulators SDHD and BCO2, and cell division genes including CDC7 and PIK3R5. For instance, the variant rs10191360 mapped to the CXCR4 gene achieved consistent effect directions across all four cohorts and reached genome-wide significance, corroborating previous independent associations with multiple sclerosis and supporting a shared molecular architecture across systemic autoimmune disorders.
To explore uncaptured discovery potential, the investigators modeled local heritability across 2,495 linkage disequilibrium blocks using the LAVA software framework. Although regions displaying high local heritability harbored a majority of the known susceptibility loci, significant variants also emerged within blocks exhibiting lower overall heritability, though these displayed systematically smaller effect sizes. Among loci classified as possessing high potential for novel discovery, one prominent region on chromosome 10 containing RPL21P16, PLPP4, and WDR11 displayed substantial local heritability while lacking significant single-nucleotide polymorphisms, a genomic segment previously associated with cardiometabolic indicators such as body mass index, high-density lipoprotein cholesterol, systolic blood pressure, and type 2 diabetes.
Stratified linkage disequilibrium score regression demonstrated that genetic variants driving psoriasis heritability were predominantly active in blood and immune compartments, with the strongest tissue-specific enrichment detected in synovial fluid and chromatin marks specific to T helper 17 cells. Expanding this approach to assess genetic correlation across 113 complex traits identified 41 significant sharing profiles after rigorous Bonferroni correction. Positive genetic correlations emerged with type 2 diabetes, ischemic heart disease, and inflammatory bowel disease, aligning with epidemiological links to metabolic and cardiovascular comorbidities. Psoriasis risk was also positively correlated with psychiatric traits, including major depressive disorder and attention-deficit/hyperactivity disorder, as well as subjective health dissatisfaction and time spent watching television. Conversely, high-density lipoprotein cholesterol exhibited a significant negative genetic correlation with psoriasis susceptibility, while low-density lipoprotein and total cholesterol levels showed no detectable genetic associations.
To determine which cell types manifest these genetic predispositions within tissue, the authors analyzed single-cell RNA sequencing data spanning 14 lesional skin samples, 11 non-lesional samples from patients, and 8 normal skin control biopsies. Batch-corrected clustering organized the cells into ten major cutaneous cell types and 55 finely resolved cellular subtypes. Applying the single-cell disease relevance score algorithm, which projects genome-wide association z-scores onto single-cell gene expression distributions, confirmed intense disease enrichment across all myeloid and T-cell subtypes. Notably, Langerhans cells and cycling myeloid cells exhibited particularly elevated scores, while among lymphocytes, cytotoxic Tc17 cells and helper T cells showed high enrichment. Beyond classical immune lineages, a distinct basal keratinocyte cluster and an endothelial cell subset expressing CDKN1A demonstrated significant polygenic disease associations. The disease-associated endothelial cells exhibited upregulated signaling in the advanced glycation end-products pathway and negative regulation of transforming growth factor-beta receptor activity.
Epidermal keratinocytes displayed a gradual differentiation trajectory along a pseudotime axis that mirrored the anatomical stratification from the deep basal layer to the superficial granular and cornified layers. Basal keratinocytes expressed structural markers KRT5 and KRT14, while spinous and granular populations expressed KRT1 and KRT10, terminating in specialized cells expressing the cornification marker filaggrin. Trajectory inference and RNA velocity modeling indicated that keratinocytes from psoriatic lesions diverged toward an altered differentiation state compared to normal skin cells. Lesional skin was enriched for a distinct keratinocyte lineage that displayed marked upregulation of inflammatory alarmins S100A7, S100A8, and S100A9. Intriguingly, the most differentiated keratinocyte subpopulations undergoing terminal cornification in the granular layer exhibited the highest single-cell disease relevance scores, indicating that inherited psoriasis risk fundamentally alters late-stage epidermal maturation.
To translate these genetic and cellular observations into actionable pharmacology, the researchers implemented a multi-stage gene prioritization workflow evaluated against five independent criteria: physical genomic proximity within 10 kilobases of a lead variant, MAGMA gene-level significance, transcriptome-wide association across skin and blood tissues, Bayesian colocalization with expression quantitative trait loci exceeding an 80 percent posterior probability, and expression in at least 10 percent of cells within disease-relevant lineages. Of 110 candidate genes satisfying at least four criteria, 50 were corroborated using summary-based Mendelian randomization and heterogeneity in dependent instruments testing in skin and whole blood datasets. Four of the prioritized genes—IL23A, TYK2, IL2RA, and VKORC1—serve as targets for approved pharmaceutical agents, while approximately half of the remaining candidates are actively undergoing preclinical or clinical evaluation. Tissue-specific regulatory discordance was detected for several genes; alleles driving psoriasis risk reduced skin expression of RGS14, NEK6, PRDX5, and FKBPL while increasing their expression in whole blood, whereas risk alleles for PRSS53 enhanced skin expression and repressed blood levels.
High-dimensional weighted gene co-expression network analysis across major skin cell lineages resolved 12 disease-relevant co-expression modules that contained two or more prioritized therapeutic targets, including four modules in keratinocytes, six in myeloid cells, and two in T cells. Within myeloid cells, the module MYE-M2 was specifically enriched in Langerhans cells, with the interleukin-23 subunit gene IL23A acting as a central network hub alongside cell surface markers CD207 and HLA-DQB2 and lipid metabolism regulators ACOT7 and LPAR3. Analysis of network topology revealed that psoriatic lesions suffered a marked disruption in the connectivity of genes governing lipoxin biosynthesis, an endogenous anti-inflammatory pathway critical for immunoregulation and tissue repair. In basal keratinocytes, module KER-M1 coordinated genes governing extracellular matrix remodeling and cell-cell adhesion, directly engaging with a myeloid module specific to type-2 conventional dendritic cells.
To evaluate how these gene networks behave during targeted biologic therapy, the investigators analyzed longitudinal single-cell transcriptomic profiles from five psoriasis patients receiving the interleukin-23 inhibitor risankizumab across baseline, day 3, and day 14 of treatment. While basal keratinocyte modules showed baseline hyperactivity that shifted following treatment, the superficial keratinocyte module KER-M3 was initially suppressed in lesional tissue and progressively restored its activity following drug administration. Intercellular communication modeling using MultiNicheNet revealed heightened receptor-ligand pairing between basal keratinocytes and type-2 conventional dendritic cells via DSC2 and DSG3, alongside upregulated immune checkpoint engagement between dendritic cells and T cells through CD80 and CTLA4. Spatial transcriptomic profiling across 14 lesional and seven normal skin biopsies confirmed the physical co-localization of basal keratinocytes and type-2 conventional dendritic cells in diseased tissue, with Lee’s spatial association statistic correlating positively with clinical Psoriasis Area and Severity Index scores.
The study synthesizes these observations into a dual-layer pathogenic mechanism within the skin microenvironment during active disease. Simultaneously, in the superficial granular layer, altered communication between differentiating keratinocytes and resident Langerhans cells disrupts lipid metabolism and autophagic regulation, driving aberrant cornification and sustained interleukin-23 production. Long-term single-cell transcriptomic validation from an independent cohort of patients evaluated 28 weeks after risankizumab initiation confirmed that sustained targeted therapy reverses these module-level cell-cell interactions and shifts global lesional gene expression back toward healthy baseline states.
Despite these extensive multi-omic integrations, the authors highlighted several methodological limitations that frame the interpretation of their findings. The primary genome-wide meta-analysis was conducted exclusively in cohorts of European ancestry, underscoring the necessity of future genomic studies across diverse racial and ancestral populations. Furthermore, the inclusion of individuals with comorbid psoriatic arthritis may account for observed heritability enrichment in synovial fluid, making it challenging to separate purely cutaneous genetic architecture from systemic joint inflammation. Available single-cell datasets lacked comprehensive demographic stratification, were skewed toward male participants, and could not resolve known sex-specific endocrine influences on disease severity. Finally, the researchers emphasized that the identified cell-cell communication networks, including the basal keratinocyte-dendritic cell interactions and CD80-CTLA4 pairings, represent computationally inferred associations that require direct functional validation through skin organoid models and gene-editing assays to definitively establish causal mechanisms.
Subject of Research: Genomic and single-cell transcriptomic mapping of susceptibility loci and therapeutic targets in psoriasis
Article Title: Integration of GWAS and single-cell analysis for psoriasis identifies disease-associated cell subtypes and therapeutic targets
Article References: Jo, H., Ahn, Y., Kim, B., Song, M., Shim, I., Kim, S., Kim, H., Hong, S., Park, W.-Y., & Won, H.-H. (2026). Integration of GWAS and single-cell analysis for psoriasis identifies disease-associated cell subtypes and therapeutic targets. Nature Communications, 17(1), Article 10260. https://doi.org/10.1038/s41467-026-77309-2
Image Credits: AI Generated
DOI: 10.1038/s41467-026-77309-2
Keywords: psoriasis, genome-wide association study, single-cell RNA sequencing, susceptibility loci, therapeutic targets, keratinocytes, myeloid cells, T cells, Langerhans cells, dendritic cells, risankizumab, interleukin-23, polygenic risk score, immunometabolism, spatial transcriptomics, colocalization, Mendelian randomization


3 hours ago
9




















English (US) ·
French (CA) ·